Loading...
•
Dec 31, 2024
ClearPoint Neuro Q4 2024 Earnings Report
ClearPoint Neuro reported a strong fourth quarter and full-year 2024 financial performance, achieving record revenue and significantly reducing operational cash burn.
Key Takeaways
ClearPoint Neuro, Inc. announced record revenue of $7.8 million for the fourth quarter of 2024, a 14% increase year-over-year, and $31.4 million for the full year, up 31% from 2023. The company also reduced its total 2024 operational cash burn by 35% to $9.0 million.
Fourth quarter 2024 revenue increased by 14% year-over-year to $7.8 million.
Full year 2024 revenue reached a record $31.4 million, marking the tenth consecutive year of growth.
Operational cash burn for 2024 was reduced by 35% compared to 2023, totaling $9.0 million.
The company activated 25 new global centers in 2024, approximately three times its historic activation rate.
Revenue by Segment
Forward Guidance
ClearPoint Neuro estimates its 2025 revenue to be between $36.0 million and $41.0 million, representing a growth of 15% to 31%. The company plans to extend its lead in drug delivery, expand its global footprint, and accelerate the launch of new products.
Positive Outlook
- Estimated revenue growth of 15% to 31% in 2025.
- Plans to extend leadership as a premier drug delivery partner for neuro disorders.
- Intends to build a leading solution in the drug delivery ecosystem, including hardware, software, and services.
- Aims to expand global footprint and regulatory clearances to increase patient capacity.
- Will accelerate the launch of new fast, simple, and predictable products for MRI Suite and Operating Room.
Challenges Ahead
- No specific negative forward guidance was provided in the report.
- The company did not highlight any specific challenges or risks for the upcoming year in the guidance section.
- No mention of potential market headwinds or increased competition.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...